PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Clinical trial NCT00759928 · COMPLETED

Trial details

NCT number: NCT00759928
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors

Start date: 2008-10-01
Primary completion: 2013-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.